NIMC
GILD icon

NWQ Investment Management Company’s Gilead Sciences GILD Stock Holding History

NWQ Investment Management Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-55,200
Closed -$5.42M – 152
2015
Q1 		$5.42M Buy
+55,200
New +$5.61M 0.07% 121

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

NWQ Investment Management Company's GILD Position: Q1 2020 in Review

NWQ Investment Management Company sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 928,842 shares — an estimated $60.4M sold.

NWQ Investment Management Company first reported a position in GILD in Q1 2015 and held it in 20 quarters. The position peaked at $60.4M in Q4 2019. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • NWQ Investment Management Company reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • NWQ Investment Management Company sold 928,842 Gilead Sciences shares in Q1 2020, an estimated $60.4M.
  • NWQ Investment Management Company first reported a position in Gilead Sciences in Q1 2015 and held it in 20 quarters.
  • NWQ Investment Management Company's Gilead Sciences position peaked at $60.4M in Q4 2019.
  • 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on NWQ Investment Management Company's 13F filing for Q1 2020, filed 14 May 2020.